BASILEA PHARMACEUTICA Trademark

Trademark Overview

On Tuesday, November 1, 2016, a trademark application was filed for BASILEA PHARMACEUTICA with the United States Patent and Trademark Office. The USPTO has given the BASILEA PHARMACEUTICA trademark a serial number of 87980984. The federal status of this trademark filing is REGISTERED as of Tuesday, July 2, 2019. This trademark is owned by Basilea Pharmaceutica International Ltd.. The BASILEA PHARMACEUTICA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products and preparations for the treatment and prevention of infections caused by bacteria
basilea pharmaceutica

General Information

Serial Number87980984
Word MarkBASILEA PHARMACEUTICA
Filing DateTuesday, November 1, 2016
Status700 - REGISTERED
Status DateTuesday, July 2, 2019
Registration Number5795819
Registration DateTuesday, July 2, 2019
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 3, 2017

Trademark Statements

Goods and ServicesPharmaceutical products and preparations for the treatment and prevention of infections caused by bacteria
Disclaimer with Predetermined Text"PHARMACEUTICA"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, November 4, 2016
Primary Code005
First Use Anywhere DateTuesday, April 9, 2019
First Use In Commerce DateTuesday, April 9, 2019

Trademark Owner History

Party NameBASILEA PHARMACEUTICA INTERNATIONAL AG,ALLSCHWIL
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressALLSCHWIL 4123
CH
Party NameBasilea Pharmaceutica International Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBasel 4058
CH
Party NameBasilea Pharmaceutica International Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel 4058
CH
Party NameBasilea Pharmaceutica International Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
Address4058 Basel
CH

Trademark Events

Event DateEvent Description
Wednesday, June 28, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, July 2, 2019REGISTERED-PRINCIPAL REGISTER
Wednesday, May 29, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, May 28, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, May 21, 2019STATEMENT OF USE PROCESSING COMPLETE
Friday, May 3, 2019USE AMENDMENT FILED
Tuesday, May 21, 2019DIVISIONAL PROCESSING COMPLETE
Friday, May 3, 2019DIVISIONAL REQUEST RECEIVED
Monday, May 20, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, May 3, 2019TEAS REQUEST TO DIVIDE RECEIVED
Friday, May 3, 2019TEAS STATEMENT OF USE RECEIVED
Friday, November 2, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 31, 2018SOU EXTENSION 2 GRANTED
Wednesday, October 31, 2018SOU EXTENSION 2 FILED
Wednesday, October 31, 2018TEAS EXTENSION RECEIVED
Friday, May 11, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 9, 2018SOU EXTENSION 1 GRANTED
Wednesday, May 9, 2018SOU EXTENSION 1 FILED
Wednesday, May 9, 2018TEAS EXTENSION RECEIVED
Tuesday, November 28, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 3, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 3, 2017PUBLISHED FOR OPPOSITION
Wednesday, September 13, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, August 25, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, August 11, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 10, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 10, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 10, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, February 10, 2017NON-FINAL ACTION E-MAILED
Friday, February 10, 2017NON-FINAL ACTION WRITTEN
Wednesday, February 8, 2017ASSIGNED TO EXAMINER
Friday, November 4, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 4, 2016NEW APPLICATION ENTERED

Related Keywords

pharmaceutica basilea infections caused bacteria prevention treatment products preparations pharmaceutical